RUNX3 and acute myeloid leukemia: Annexin V and 7-AAD double staining showed that upon Runx3 knockdown, the percentage of total apoptotic cells in AML cells was remarkably increased to 13.4% compared with 8.6% in control group (1.56-fold increase) (Figure 3D).